Skip to main content

Table 4 Multi-drug resistance profile of A. baumannii and P. aeruginosa isolates from patients clinically presumptive for nosocomial infection at FHRH, 2018 (n = 20)

From: Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study

Bacterial isolate

Antibiogram Profile

Antibiotic Class

Frequency

N (%)

Over all, MDR

A. baumannii (n = 9)

(AMP,AMC,CAZ,PIP,CIP,CN,SXT,MEM)

6

3 (33.3)

 

(AMP,AMC,CAZ,PIP,CN,SXT)

4

2 (22.2)

 

(AMP,AMC,CAZ,PIP,CIP,CN)

4

1 (11.1)

 

(AMP,AMC,PIP,CN,SXT)

3

2 (22.2)

 

(AMP,CAZ,PIP,SXT)

3

1 (11.1)

 
 

9 (100)

P. aeruginosa (n = 11)

(AMP,AMC,CAZ,PIP,CIP,CN,SXT,MEM)

6

4 (36.4)

 

(AMP,AMC,CAZ,PIP,CIP,SXT)

4

1 (91.)

 

(AMP,AMC,PIP,CN,SXT)

3

2 (18.2)

 

(AMP,AMC,CAZ,PIP,SXT)

3

4 (36.4)

 
 

11 (100)

  1. Key: AMP: Ampicillin, AMC: Amoxicillin-clavulanic acid, PIP: Piperacillin, CAZ: Ceftazidime, CIP: Ciprofloxacin, CN: Gentamicin, MEM: Meropenem and SXT: Sulphamethoxazole- Trimethoprim, R3,4,6,: resistance to 3,4,6 antibiotic drug classes